Corcept Therapeutics, Inc. (CORT)
46.06
+0.98
(+2.17%)
USD |
NASDAQ |
Apr 24, 16:00
47.43
+1.37
(+2.97%)
After-Hours: 04:10
Corcept Therapeutics Market Cap : 4.900B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 276.66B |
| Integer Holdings Corp. | 2.960B |
| Supernus Pharmaceuticals, Inc. | 2.865B |
| Terns Pharmaceuticals, Inc. | 6.104B |
| ACADIA Pharmaceuticals, Inc. | 3.744B |
Market Cap Related Metrics
| PE Ratio | 56.30 |
| PS Ratio | 7.253 |
| Price to Book Value | 7.563 |
| Price to Free Cash Flow | 38.95 |
| Price | 46.06 |
| Earnings Yield | 1.78% |
| Operating PE Ratio | 123.28 |
| Normalized PE Ratio | 56.30 |